Therapeutic potential of Terminalia arjuna in cardiovascular disorders. - Wikidata - wikimedia - TriplyDB

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

http://www.wikidata.org/entity/Q38009875

about

Revisiting Terminalia arjuna - An Ancient Cardiovascular Drug Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis.DNA-based Simultaneous Identification of Three Terminalia Species Targeting Adulteration Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.A survey of medicinal plants used by the Deb barma clan of the Tripura tribe of Moulvibazar district, Bangladesh Arjunolic Acid, a Peroxisome Proliferator-Activated Receptor Alpha Agonist Regresses Cardiac Fibrosis by Inhibiting Non-canonical TGF-β Signaling.Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.In vitro and in vivo Evaluation of CYP1A Interaction Potential of Terminalia Arjuna Bark.In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes.Cardioprotective role of methanolic extract of bark of Terminalia arjuna against in-vitro model of myocardial ischemic-reperfusion injury.Effect of Chinese Medicine Danshen and Indian Ayurvedic Medicine Bark of Arjuna Tree on a Relatively New LOCI Digoxin Assay for Application on the Vista 1500 Analyzer.

P2860

Q26991799-DA0E42DC-E8E4-4EC4-B8A2-6230B873FA17 Q35112258-D2F382DB-357C-40C3-874B-AE9E79ECDD69 Q37149029-2DEF0B99-FD75-4CA7-B45A-2D67C187769B Q37544048-6D7AA739-D817-4F2E-8018-9E27697D750A Q37717487-FF8D4F2D-7D8A-4A2C-9BBB-4466FC2E39B8 Q38618013-A1B4506B-DF33-4561-AD99-85BA9B60C64E Q38892475-9E79AABA-33F3-448C-9A3C-B3B96FAE8B3F Q39671913-B6F5F022-5363-4778-8FE0-8A1FF1DCD242 Q41680453-1FD8A212-6534-4505-9974-64C00A3786A9 Q41988462-CADC7BB2-03D7-42A1-AE17-CEB6976DE857 Q47642615-89B73587-D4CE-4C84-85A4-3D50861A9B57

P2860

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

http://www.wikidata.org/entity/Q38009875

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

@en

type

label

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

@en

prefLabel

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

@en

P1433

Q38009875-148E004D-E89F-48C2-A80C-1796B0A82F81

P1476

Q38009875-4A905A90-F16A-483D-9075-5AB61B614D41

P2093

Q38009875-4BB417A6-F982-47C2-BE68-F1C75AC9F78C

P2860

Q38009875-04A35AAF-DAA8-41D5-BA3E-EAB44B0C81E6

Q38009875-1A35EE0C-C35E-4611-B5CF-2A7F0D7A9CB7

Q38009875-3C8ECA6A-0930-42D3-A868-87EF1E9BB0D4

Q38009875-3CA67F99-7F74-496B-A2B0-B9A2CD96693F

Q38009875-468FAAE0-4F4D-4192-B981-6647393D6905

Q38009875-4B715BCC-2EA8-4CF7-8DD3-B09E36DF601D

Q38009875-5B8EF7C3-EAD9-477B-9D96-96760A198F66

Q38009875-65E46E46-3AC1-4AC7-A0CA-87997AAF2FB2

Q38009875-6F107E76-1333-4725-BCB7-7CDCAA6DD022

Q38009875-74D6EF65-0FC4-4546-949E-7B9BB9C51479

P2888

Q38009875-2C7DDC51-2410-4567-8E40-BE17F0E0C1FA

P304

Q38009875-3C4ADEE9-7392-4220-8D58-A15B0203C4D0

P31

Q38009875-7D2F6781-23FA-4056-8765-E9768C934D41

P356

Q38009875-6826BB0F-65BF-4D09-8D83-6E9A886E1585

P433

Q38009875-281F80F2-CF80-4D9A-A96E-384AAE0B5EE0

P478

Q38009875-0519A2A5-1E8E-47C1-AC27-F601E24048E9

P50

Q38009875-94D65585-5AB5-4984-A1F9-B77D723709CB

P577

Q38009875-4B0511C2-354E-4120-82DC-24CBD8A4A24D

P6179

Q38009875-2D6A8B96-7A2F-437B-A5E3-43E36C177042

P698

Q38009875-05DFB730-82CF-4C11-937F-AA15427B7C18

P356

11598990-000000000-00000

P1433

American journal of cardiovascular drugs

P1476

Therapeutic potential of Terminalia arjuna in cardiovascular disorders

@en

P2093

Subir K Maulik

http://www.w3.org/2001/XMLSchema#string

P2860

Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.

Antiatherogenic small, dense HDL--guardian angel of the arterial wall?

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Value of exercise treadmill testing in women.

Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan?

Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence.

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.

The Framingham Heart Study: impact on the prevention and control of cardiovascular diseases in India.

Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults.

Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.).

P2888

11598990-000000000-00000

P304

157-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11598990-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001537896

http://www.w3.org/2001/XMLSchema#string

P698

22583146

http://www.w3.org/2001/XMLSchema#string